Toxicity, Drug

12 registered clinical trials studyying Toxicity, Drug — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial NCT05652673	Erasmus Medical Center	N/A
Recruiting	Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia NCT05512169	University of Geneva, Switzerland	—
Completed	Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Li NCT06558084	Ain Shams University	—
Completed	Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal C NCT05355168	Anhui Provincial Hospital	Phase 2
Suspended	Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma NCT04824352	Peking University People's Hospital	Phase 2
Completed	Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma NCT04690231	Peking University People's Hospital	N/A
Completed	Observation Study of the Pharmacokinetics of Adductor Canal Block NCT04916392	The University of Hong Kong	—
Recruiting	Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning NCT04499885	Sherief Abd-Elsalam	N/A
Unknown	Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperati NCT04351308	Peking University People's Hospital	Phase 2
Completed	Apatinib for Inoperable Advanced Chondrosarcoma NCT04260113	Peking University People's Hospital	N/A
Unknown	TIL and Anti-PD1 in Metastatic Melanoma NCT03638375	Leiden University	Phase 1 / Phase 2
Completed	Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials NCT02719002	Fondation Ophtalmologique Adolphe de Rothschild	N/A